SEARCH
Surajit Pal of Prabhudas Lilladher on Dr Reddy's Laboratories
CNBC-TV18
2019-02-15
Views
2
Description
Share / Embed
Download This Video
Report
Shares of Dr Reddy's Laboratories plunged nearly 23 percent after a research report flagged USFDA observation issued at the company's formulation plant.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x72ftex" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
03:07
Interview with G.V. Prasad of Dr Reddy's Laboratories
10:06
Stocks To Watch: Dr Reddy’s Laboratories, Essel Propack & Ashok Leyland
08:09
Stocks To Watch: Steel Manufacturers, NMDC & Dr Reddy's Laboratories
06:59
Dr Reddy's Laboratories Q4 net up 2% at Rs 343 cr
09:22
Dr Reddy's Laboratories Profit Up 11%, In Line With Estimates | NDTV Profit
04:33
Buy Ashok Leyland & Dr Reddy's Laboratories, says stock expert Prakash Gaba
06:24
Stronger Q2 From Dr Reddy's Laboratories
01:56
Dr Reddy's Laboratories & Lupin will be in focus today
05:14
महापालिकेचे लसीसाठीचे प्रयत्न फोल | Sputnik V | Dr Reddy’s Laboratories | BMC | Mumbai News
02:20
Dr. Muhammad Nadeem Sarwar (MD Sanna Laboratories talked with Waheed Jang in LDFA Expo 2015 at Karachi.
02:56
Dr Reddy Laboratories Plant Gets EIR From U.S. FDA For Its Visakhapatnam Facility
02:04
Dr. Muhammad Nadeem Sarwar (MD Sanna Laboratories talked with Naveed Farooqi in LDFA Expo 2015 at Karachi.
